https://www.prnewswire.com/news-releases/novogen-to-present-at-2nd-annual-sachs-cancer-bio-partnering--investment-forum-in-new-york-249775501.html
/PRNewswire/ -- Novogen Limited (ASX: NRT; NASDAQ: NVGN), an oncology drug development company, today announced that Graham Kelly, Ph.D., Executive Director...
novogenpresentannualsachscancer
https://www.prnewswire.com/news-releases/novogen-and-cantx-experimental-drug-trx-1-proves-effective-in-vivo-250763261.html
/PRNewswire/ -- Novogen Limited [ASX:NRT; NASDAQ:NVGN] and its joint venture company with Yale University, CanTx Inc, today announced an important milestone...
experimental drugnovogentrxproveseffective